Hans J.M. Smit

3.4k total citations
56 papers, 1.7k citations indexed

About

Hans J.M. Smit is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hans J.M. Smit has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 8 papers in Surgery. Recurrent topics in Hans J.M. Smit's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Diagnosis and Treatment (21 papers) and Lung Cancer Research Studies (13 papers). Hans J.M. Smit is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Diagnosis and Treatment (21 papers) and Lung Cancer Research Studies (13 papers). Hans J.M. Smit collaborates with scholars based in Netherlands, United Kingdom and Germany. Hans J.M. Smit's co-authors include Franz M.N.H. Schramel, Bonne Biesma, Egbert F. Smit, Harry J.M. Groen, Jos A. Stigt, Otilia Dalesio, Giuseppe Giaccone, Catherine Legrand, Andrew Vincent and C. Debruyne and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and CHEST Journal.

In The Last Decade

Hans J.M. Smit

54 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans J.M. Smit Netherlands	20	1.3k	950	269	164	109	56	1.7k
Yuki Sato Japan	21	801 0.6×	834 0.9×	166 0.6×	123 0.8×	119 1.1×	108	1.5k
Nurullah Zengin Türkiye	21	479 0.4×	787 0.8×	300 1.1×	187 1.1×	56 0.5×	160	1.5k
Ian T. Jones Australia	23	443 0.3×	1.1k 1.2×	640 2.4×	223 1.4×	58 0.5×	74	1.8k
Keiichiro Ishibashi Japan	19	522 0.4×	809 0.9×	588 2.2×	164 1.0×	40 0.4×	194	1.5k
L Bonelli Italy	22	680 0.5×	1.1k 1.2×	608 2.3×	225 1.4×	85 0.8×	66	1.7k
Chung-Yuan Hu United States	21	710 0.6×	2.1k 2.3×	1.1k 4.2×	168 1.0×	44 0.4×	30	2.7k
Abdurrahman Işıkdoğan Türkiye	19	424 0.3×	537 0.6×	204 0.8×	204 1.2×	79 0.7×	146	1.2k
Brian K. Bednarski United States	24	470 0.4×	1.4k 1.5×	874 3.2×	214 1.3×	39 0.4×	90	2.1k
Kathryn Richert-Boe United States	17	393 0.3×	531 0.6×	140 0.5×	224 1.4×	94 0.9×	36	972
Timothy R. Asmis Canada	19	420 0.3×	758 0.8×	237 0.9×	258 1.6×	54 0.5×	66	1.3k

Countries citing papers authored by Hans J.M. Smit

Since Specialization

Citations

This map shows the geographic impact of Hans J.M. Smit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans J.M. Smit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans J.M. Smit more than expected).

Fields of papers citing papers by Hans J.M. Smit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans J.M. Smit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans J.M. Smit. The network helps show where Hans J.M. Smit may publish in the future.

Co-authorship network of co-authors of Hans J.M. Smit

This figure shows the co-authorship network connecting the top 25 collaborators of Hans J.M. Smit. A scholar is included among the top collaborators of Hans J.M. Smit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans J.M. Smit. Hans J.M. Smit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jong, Peter J. de, Theo van Voorthuizen, Rob ter Heine, et al.. (2025). Pharmacokinetic Study of Carboplatin Using Various Overweight-Correcting Dosing Algorithms and Biomarkers in Patients With Varying BMI Categories. Therapeutic Drug Monitoring. 47(6). 730–739.

Schuurbiers, Olga C.J., et al.. (2024). 1234P Stage migration in resectable NSCLC. Annals of Oncology. 35. S791–S791. 1 indexed citations

Böhringer, Stefan, Hans J.M. Smit, Pepijn Brocken, et al.. (2024). Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective. Lung Cancer. 196. 107950–107950. 3 indexed citations

Hendriks, Lizza, Simon Keek, Avishek Chatterjee, et al.. (2022). 127P Does radiomics have added value in predicting the development of brain metastases in patients with radically treated stage III non-small cell lung cancer (NSCLC)?. Annals of Oncology. 33. S91–S91. 1 indexed citations

Hugen, Niek, et al.. (2021). Efficacy of an Autologous Blood Patch for Prolonged Air Leak: A Systematic Review. The Annals of Thoracic Surgery. 114(3). 1064–1071. 12 indexed citations

Hendriks, Lizza, Vincent van der Noort, Franz M.N.H. Schramel, et al.. (2020). Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial. Frontiers in Oncology. 10. 890–890. 4 indexed citations

Breugem, Corstiaan C., Hans J.M. Smit, Hans Mark, et al.. (2020). Prioritizing Cleft/Craniofacial Surgical Care after the COVID-19 Pandemic. Plastic & Reconstructive Surgery Global Open. 8(9). e3080–e3080. 6 indexed citations

Smit, Hans J.M., Joachim G.J.V. Aerts, Michel M. van den Heuvel, et al.. (2019). Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry. Lung Cancer. 140. 107–112. 20 indexed citations

Smit, Hans J.M., et al.. (2017). Post-mortem findings in 22 fatal Taxus baccata intoxications and a possible solution to its detection. Journal of Forensic and Legal Medicine. 52. 56–61. 13 indexed citations

10.

Groen, Harry J.M., Erik H.F.M. van der Heijden, Theo J. Klinkenberg, et al.. (2016). Randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in completely resected non-small cell lung cancer patients: The NVALT-8 study.. Journal of Clinical Oncology. 34(15_suppl). 8506–8506. 8 indexed citations

11.

Kuiper, Justine L., Lizza Hendriks, Anthonie J. van der Wekken, et al.. (2015). Treatment and survival of patients with EGFR -mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis. Lung Cancer. 89(3). 255–261. 95 indexed citations

12.

Biesma, Bonne, A.N.M. Wymenga, Andrew Vincent, et al.. (2011). Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study. Annals of Oncology. 22(7). 1520–1527. 79 indexed citations

13.

Smit, Egbert F., Harry J.M. Groen, Hans J.M. Smit, et al.. (2008). A randomized phase II study of pemetrexed (P) versus pemetrexed-carboplatin (PC) as second line treatment for patients (pts) with advanced non-small-cell lung cancer (NSCLC)- NVALT 7. Journal of Clinical Oncology. 26(15_suppl). 8050–8050. 7 indexed citations

14.

Biesma, Bonne, Andrew Vincent, Otilia Dalesio, et al.. (2007). P2-239: A randomized phase III study of carboplatin-gemcitabine (CG) versus carboplatin-paclitaxel (CP) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC) with emphasis on geriatric assessment and quality of life (QoL): The NVALT-3 study. Journal of Thoracic Oncology. 2(8). S667–S668. 5 indexed citations

15.

Scagliotti, Giorgio V., Christopher Kaiser, Bonne Biesma, et al.. (2007). C6-01: Correlations of biomarker expression and clinical outcome in a large phase III trial of pemetrexed plus cisplatin or gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S375–S375. 9 indexed citations

16.

Bottomley, Andrew, Egbert F. Smit, Fabio Efficace, et al.. (2005). Non-small cell lung cancer and health-related quality of life (HRQOL): Is baseline HRQOL of prognostic value for survival?. Open Repository and Bibliography (University of Liège). 1 indexed citations

17.

Smit, Hans J.M., Richard P. Golding, Franz M.N.H. Schramel, et al.. (2004). Lung Density Measurements in Spontaneous Pneumothorax Demonstrate Airtrapping. CHEST Journal. 125(6). 2083–2090. 17 indexed citations

18.

Smit, Hans J.M., Richard P. Golding, Franz M.N.H. Schramel, et al.. (2003). Lung Attenuation Measurements in Healthy Young Adults. Respiration. 70(2). 143–148. 4 indexed citations

19.

Smit, Hans J.M., et al.. (1997). Video‐Assisted Thoracoscopy is Feasible Under Local Anesthesia. Diagnostic and therapeutic endoscopy. 4(4). 177–182. 10 indexed citations

20.

Smit, Hans J.M., et al.. (1996). Is Resection of Bronchiectasis Beneficial in Patients With Primary Ciliary Dyskinesia?. CHEST Journal. 109(6). 1541–1544. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact